Wissenschaftlich verantwortlich gemäß Zertifizierungsbestimmungen Wissenschaftlich verantwortlich gemäß Zertifizierungs- bestimmungen: PD Dr. med. Isabel V. Wagner, Lübeck Literatur [1] Lee PA, Nordenström A, Houk CP et al. Global Disorders of Sex Development Update since 2006: Perceptions, Approach and Care. Horm Res Paediatr 2006; 85: 158–180 [2] Nielsen J, WohlerM. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet 1991; 87: 81–83 [3] Lindhardt Johansen M, Hagen CP, Rajpert-De Meyts E et al. 45, X/46,XY mosaicism: phenotypic characteristics, growth, and reproductive function–a retrospective longitudinal study. J Clin Endocrinol Metab 2012; 97: E1540–E1549 [4] Hughes IA. Disorders of sex development: a new definition and classification. Best Pract Res Clin Endocrinol Metab 2008; 22: 119–134. doi:10.1016/j.beem.2007.11.001 [5] Hughes IA, Houk C, Ahmed SF et al. Consensus statement on management of intersex disorders. J Pediatr Urol 2006; 2: 148–162. doi:10.1542/peds.2006-0738 [6] Werner R, Merz H, Birnbaum W et al. 46,XY Gonadal Dysgene- sis due to a Homozygous Mutation in Desert Hedgehog (DHH) Identified by Exome Sequencing. J Clin Endocrinol Metab 2015; 100: E1022–E1029. doi:10.1210/jc.2015-1314 [7] Werner R, Monig I, Lunstedt R et al. New NR5A1 mutations and phenotypic variations of gonadal dysgenesis. PLoS One 2017; 12: e0176720. doi:10.1371/journal.pone.0176720 [8] Reardon S. The spectrum of sex development: Eric Vilain and the intersex controversy. Nature 2016; 533: 160–163. doi:10.1 038/533160a [9] Andrade JGR, Fabbri-Scallet H, Dos Santos AP et al. Clinical Findings and Follow-Up of 46,XY and 45,X/46,XY Testicular Dysgenesis. Sex Dev 2019; 13: 171–177. doi:10.1159/00050 4239 [10] Savage MO, Lowe DG. Gonadal neoplasia and abnormal sexual differentiation. Clin Endocrinol (Oxf) 1990; 32: 519–533. doi:1 0.1111/j.1365-2265.1990.tb00893.x [11] Kalra R, Cameron M, Stern C. Female fertility preservation in DSD. Best Pract Res Clin Endocrinol Metab 2019; 33: 101289. doi:10.1016/j.beem.2019.101289 [12] Hiort O, Marshall L, Birnbaum W et al. Pubertal Development in 17Beta-Hydroxysteroid Dehydrogenase Type 3 Deficiency. Horm Res Paediatr 2017; 87: 354–358 [13] Imperato-McGinley J. 5alpha-reductase-2 deficiency and com- plete androgen insensitivity: lessons from nature. Adv Exp Med Biol 2002; 511: 121–131. doi:10.1007/978-1-4615-0621-8_8 [14] Imperato-McGinley J, Peterson RE, Gautier T et al. Hormonal evaluation of a large kindred with complete androgen insensi- tivity: evidence for secondary 5 alpha-reductase deficiency. J Clin Endocrinol Metab 1982; 54: 931–941 [15] Imperato-McGinley J, Zhu YS. Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency. Mol Cell Endo- crinol 2002; 198: 51–59. doi:10.1016/s0303-7207(02)00368- 4 [16] Audi L, Ahmed SF, Krone N et al. Genetics in Endocrinology: Approaches to molecular genetic diagnosis in the manage- ment of differences/disorders of sex development (DSD): posi- tion paper of EU COST Action BM 1303 ‘DSDnet’. Eur J Endocri- nol 2018; 179: R197–R206. doi:10.1530/EJE-18-0256 [17] Sinnecker GH, Hiort O, Dibbelt L et al. Phenotypic classification of male pseudohermaphroditism due to steroid 5 alpha-reduc- tase 2 deficiency. Am J Med Genet 1996; 63: 223–230. doi:10. 1002/(SICI)1096-8628(19960503)63:1223::AID-AJMG393.0. CO;2-O [18] Quigley CA, De Bellis A, Marschke KB et al. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 1995; 16: 271–321. doi:10.1210/edrv-16-3-271 [19] Gottlieb B, Beitel LK, Wu J et al. Nuclear receptors and disease: androgen receptor. Essays Biochem 2004; 40: 121–136. doi:1 0.1042/bse0400121 [20] Han TS, Goswami D, Trikudanathan S et al. Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis. Eur J Endocrinol 2008; 159: 179–185 [21] Doehnert U, Bertelloni S, Werner R et al. Characteristic fea- tures of reproductive hormone profiles in late adolescent and adult females with complete androgen insensitivity syndrome. Sex Dev 2015; 9: 69–74 [22] Johannsen TH, Andersson AM, Ahmed SF et al. Peptide hor- mone analysis in diagnosis and treatment of Differences of Sex Development: joint position paper of EU COST Action ‘DSDnet’ and European Reference Network on Rare Endocrine Condi- tions. Eur J Endocrinol 2020; 182: P1–P15. doi:10.1530/EJE-19- 0831 [23] Looijenga LH, Hersmus R, Oosterhuis JW et al. Tumor risk in disorders of sex development (DSD). Best Pract Res Clin Endo- crinol Metab 2007; 21: 480–495. doi:10.1159/000314536 [24] Looijenga LHJ, Kao CS, Idrees MT. Predicting Gonadal Germ Cell Cancer in People with Disorders of Sex Development; In- sights from Developmental Biology. Int J Mol Sci 2019; 20: 5017. doi:10.3390/ijms20205017 [25] Doehnert U, Wunsch L, Hiort O. Gonadectomy in Complete Androgen Insensitivity Syndrome: Why and When? Sex Dev 2017; 11: 171–174 [26] Birnbaum W, Marshall L, Werner R et al. Oestrogen versus an- drogen in hormone-replacement therapy for complete andro- gen insensitivity syndrome: a multicentre, randomised, dou- ble-dummy, double-blind crossover trial. Lancet Diabetes En- docrinol 2018; 6: 771–780. doi:10.1016/S2213-8587(18)301 97-9 [27] T’Sjoen G, De Cuypere G, Monstrey S et al. Male gender iden- tity in complete androgen insensitivity syndrome. Arch Sex Be- hav 2011; 40: 635–638. doi:10.1007/s10508-010-9624-1 [28] Hornig NC, Holterhus PM. Molecular basis of androgen insensi- tivity syndromes. Mol Cell Endocrinol 2021; 523: 111146. doi:10.1016/j.mce.2020.111146 [29] Imbeaud S, Belville C, Messika-Zeitoun L et al. A 27 base-pair deletion of the anti-mullerian type II receptor gene is the most common cause of the persistent mullerian duct syndrome. Hum Mol Genet 1996; 5: 1269–1277 [30] Narita O, Manba S, Nakanishi T et al. Pregnancy and childbirth in a true hermaphrodite. Obstet Gynecol 1975; 45: 593–595 [31] McElreavey K, Fellous M. Sex-determining genes. Trends Endo- crinol Metab 1997; 8: 342–346. doi:10.1016/s1043-2760(97)0 0135-5 [32] Prader A. [For the development of the chorda dorsalis of hu- mans]. Bull Histol Appl Physiol Pathol Tech Microsc 1945; 22: 138 Wagner I et al. Varianten der Geschlechtsentwicklung ... Pädiatrie up2date 2023; 18: 205–224 | © 2023. Thieme. All rights reserved. 221